论文部分内容阅读
目的探讨依达拉奉治疗老年脑卒中后迟发性癫痫的临床疗效。方法选取2013年11月—2014年11月徐州市第一人民医院收治的老年脑卒中后迟发性癫痫患者70例。按照随机数字表法将患者分为对照组与观察组,各35例。对照组患者给予抗癫痫常规药物治疗,观察组在对照组基础上给予依达拉奉联合治疗,比较两组患者临床疗效及不良反应发生情况。结果观察组患者总有效率高于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论依达拉奉治疗老年脑卒中后迟发性癫痫疗效确切,可有效控制癫痫发作,且不良反应少。
Objective To investigate the clinical efficacy of edaravone in the treatment of senile post-stroke delayed-onset epilepsy. Methods Seventy patients with delayed epilepsy after stroke were selected from the First People ’s Hospital of Xuzhou from November 2013 to November 2014. Patients were divided into control group and observation group according to random number table method, each 35 cases. Control group patients were given anti-epilepsy conventional drug treatment, the observation group were given edaravone combination therapy on the basis of the control group, the clinical efficacy and adverse reactions were compared between the two groups. Results The total effective rate of observation group was higher than that of control group, the incidence of adverse reactions was lower than that of control group, the difference was statistically significant (P <0.05). Conclusion Edaravone is effective in treating post-stroke epilepsy after stroke, which can effectively control the seizure with few adverse reactions.